Knee Pain Management Market by Types (Acute Knee Pain and Chronic Knee Pain), Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and E-commerce), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The global knee pain management market size is expected to expand at a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the surge in the frequency of sports injuries, the aging population, and the global patient pool are all driving global demand for knee pain management. High prevalence and incidence of osteoarthritis and rheumatoid arthritis among adult and geriatric populations.
Knee pain is a common ailment caused by the knee's bone structure. It is closely correlated with age. The location of knee pain is determined by the injured area. Limping owing to discomfort, trouble walking, climbing stairs, locking of the knee, redness, swelling, and inability to extend the knee are all symptoms of knee pain. Knee discomfort in young people is related to the overuse of knee joints as a result of physical activity or sports. It is caused by the wear and tear of the knee joint caused by osteoarthritis and rheumatoid arthritis in the elderly population.
Patients' usual lifestyles are hampered by their loss of movement and knee pain, necessitating the use of knee pain management and treatments right away. Mild knee discomfort merely causes inconvenience in daily life, however severe knee pain causes serious movement limitations. Damaged menisci, tendinitis, pseudogout, bursitis, and excess body weight are some of the other causes of knee pain.
Market Trends, Drivers, Restraints, and Opportunities:
- Rising frequency of sports injuries, the prevalence of arthritis, and the demand for treatment alternatives for the knee pain management market are expected to boost the market growth during the forecast period.
- The growing aging population, as well as the risk of infections and swellings in the knee, are all projected to propel the market expansion in the coming years.
- High prevalence and incidence of osteoarthritis and rheumatoid arthritis among adult and geriatric populations are estimated to spur the market growth in the coming years.
- Emerging therapies, such as Disease-modifying antirheumatic drugs (DMARDs) and anti-NGF, are expected to grow the global market since they allow rapid pain relief and improved knee movement in patients.
- High treatment costs, unfavorable reimbursement mainly for viscosupplementation, and generic competition are projected to impede the market expansion.
- Technological developments in joint replacement are expected to create significant opportunities in the global knee pain management market.
Scope of the Report
The report on the global knee pain management market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Knee Pain Management Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2020 |
|
Historic Data |
2018–2019 |
|
Forecast Period |
2021–2028 |
|
Segmentation |
Types (Acute Knee Pain and Chronic Knee Pain), and Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and E-commerce) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Johnson & Johnson Services, Inc., F. Hoffman-La Roche AG, Amgen, Inc., Merck & Co., Inc., and Pfizer, Inc., Ferring B.V., GlaxoSmithKline plc, Bayer AG, AstraZeneca, Sanofi S.A., Zydus Cadila, and Others |
Global Knee Pain Management Market Segment Insights:
Chronic Knee Pain segment is projected to account for a large market share
Based on types, the global knee pain management market is bifurcated into acute knee pain and chronic knee pain. The chronic knee pain segment is expected to account for a key share of the market during the forecast period due to an increase in the number of surgeries performed globally and an increase in the prevalence of chronic disorders that cause knee pain.
Hospital Pharmacies segment is expected to represent a key market share
On the basis of distribution channels, the market is segmented into hospital pharmacies, retail pharmacies, drug stores, and E-commerce. The hospital pharmacies segment is expected to constitute a key share of the market during the forecast period owing to the high number of patients visiting hospitals for knee pain treatments and the huge choice of knee pain treatments accessible in hospital pharmacy, hospital pharmacies accounted for the greatest proportion of the market, another significant benefit is the ease with which reimbursements can be obtained for purchases made at hospital pharmacies.
North America is anticipated to dominate the market
In terms of regions, the global knee pain management market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market at a healthy CAGR during the forecast period. The regional market growth can be attributed to the increased incidence of knee arthritis, which includes knee osteoarthritis and rheumatoid arthritis, rise in healthcare spending, an increase in knee ligament injuries, and a demand for better treatment.
Segments
Segments Covered in the Report:
The global knee pain management market has been segmented based on
Types
- Acute Knee Pain
- Chronic Knee Pain
Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- E-commerce
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Johnson & Johnson Services, Inc.
- F. Hoffman-La Roche AG
- Amgen, Inc.
- Merck & Co., Inc.
- Pfizer, Inc.
- Ferring B.V.
- GlaxoSmithKline plc
- Bayer AG
- AstraZeneca
- Sanofi S.A.
- Zydus Cadila
- Others
Competitive Landscape
Leading manufacturers operating in the global knee pain management market include Johnson & Johnson Services, Inc., F. Hoffman-La Roche AG, Amgen, Inc., Merck & Co., Inc., and Pfizer, Inc., Ferring B.V., GlaxoSmithKline plc, Bayer AG, AstraZeneca, Sanofi S.A., Zydus Cadila, and Others.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Knee Pain Management Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Knee Pain Management Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Knee Pain Management Market - Supply Chain
4.5. Global Knee Pain Management Market Forecast
4.5.1. Knee Pain Management Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Knee Pain Management Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Knee Pain Management Market Absolute $ Opportunity
5. Global Knee Pain Management Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Knee Pain Management Market Size and Volume Forecast by Types
5.3.1. Acute Knee Pain
5.3.2. Chronic Knee Pain
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Knee Pain Management Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Knee Pain Management Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Knee Pain Management Demand Share Forecast, 2019-2026
7. North America Knee Pain Management Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Knee Pain Management Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Knee Pain Management Market Size and Volume Forecast by Types
7.4.1. Acute Knee Pain
7.4.2. Chronic Knee Pain
7.5. Basis Point Share (BPS) Analysis by Types
7.6. Y-o-Y Growth Projections by Types
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Knee Pain Management Demand Share Forecast, 2019-2026
8. Latin America Knee Pain Management Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Knee Pain Management Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Knee Pain Management Market Size and Volume Forecast by Types
8.4.1. Acute Knee Pain
8.4.2. Chronic Knee Pain
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Knee Pain Management Demand Share Forecast, 2019-2026
9. Europe Knee Pain Management Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Knee Pain Management Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Knee Pain Management Market Size and Volume Forecast by Types
9.4.1. Acute Knee Pain
9.4.2. Chronic Knee Pain
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Knee Pain Management Demand Share Forecast, 2019-2026
10. Asia Pacific Knee Pain Management Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Knee Pain Management Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Knee Pain Management Market Size and Volume Forecast by Types
10.4.1. Acute Knee Pain
10.4.2. Chronic Knee Pain
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Knee Pain Management Demand Share Forecast, 2019-2026
11. Middle East & Africa Knee Pain Management Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Knee Pain Management Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Knee Pain Management Market Size and Volume Forecast by Types
11.4.1. Acute Knee Pain
11.4.2. Chronic Knee Pain
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Knee Pain Management Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Knee Pain Management Market: Market Share Analysis
12.2. Knee Pain Management Distributors and Customers
12.3. Knee Pain Management Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Johnson & Johnson Services, Inc.
12.4.2. F. Hoffman-La Roche AG
12.4.3. Amgen, Inc.
12.4.4. Merck & Co., Inc.
12.4.5. Pfizer, Inc.
12.4.6. Ferring B.V.
12.4.7. GlaxoSmithKline plc
12.4.8. Bayer AG
12.4.9. AstraZeneca
12.4.10. Sanofi S.A.
2. Assumptions and Acronyms Used
3. Research Methodology
4. Knee Pain Management Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Knee Pain Management Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Knee Pain Management Market - Supply Chain
4.5. Global Knee Pain Management Market Forecast
4.5.1. Knee Pain Management Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Knee Pain Management Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Knee Pain Management Market Absolute $ Opportunity
5. Global Knee Pain Management Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Knee Pain Management Market Size and Volume Forecast by Types
5.3.1. Acute Knee Pain
5.3.2. Chronic Knee Pain
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Knee Pain Management Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Knee Pain Management Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Knee Pain Management Demand Share Forecast, 2019-2026
7. North America Knee Pain Management Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Knee Pain Management Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Knee Pain Management Market Size and Volume Forecast by Types
7.4.1. Acute Knee Pain
7.4.2. Chronic Knee Pain
7.5. Basis Point Share (BPS) Analysis by Types
7.6. Y-o-Y Growth Projections by Types
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Knee Pain Management Demand Share Forecast, 2019-2026
8. Latin America Knee Pain Management Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Knee Pain Management Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Knee Pain Management Market Size and Volume Forecast by Types
8.4.1. Acute Knee Pain
8.4.2. Chronic Knee Pain
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Knee Pain Management Demand Share Forecast, 2019-2026
9. Europe Knee Pain Management Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Knee Pain Management Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Knee Pain Management Market Size and Volume Forecast by Types
9.4.1. Acute Knee Pain
9.4.2. Chronic Knee Pain
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Knee Pain Management Demand Share Forecast, 2019-2026
10. Asia Pacific Knee Pain Management Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Knee Pain Management Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Knee Pain Management Market Size and Volume Forecast by Types
10.4.1. Acute Knee Pain
10.4.2. Chronic Knee Pain
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Knee Pain Management Demand Share Forecast, 2019-2026
11. Middle East & Africa Knee Pain Management Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Knee Pain Management Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Knee Pain Management Market Size and Volume Forecast by Types
11.4.1. Acute Knee Pain
11.4.2. Chronic Knee Pain
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Knee Pain Management Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Knee Pain Management Market: Market Share Analysis
12.2. Knee Pain Management Distributors and Customers
12.3. Knee Pain Management Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Johnson & Johnson Services, Inc.
12.4.2. F. Hoffman-La Roche AG
12.4.3. Amgen, Inc.
12.4.4. Merck & Co., Inc.
12.4.5. Pfizer, Inc.
12.4.6. Ferring B.V.
12.4.7. GlaxoSmithKline plc
12.4.8. Bayer AG
12.4.9. AstraZeneca
12.4.10. Sanofi S.A.
Segments Covered in the Report:
The global knee pain management market has been segmented based on
Types
- Acute Knee Pain
- Chronic Knee Pain
Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- E-commerce
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Johnson & Johnson Services, Inc.
- F. Hoffman-La Roche AG
- Amgen, Inc.
- Merck & Co., Inc.
- Pfizer, Inc.
- Ferring B.V.
- GlaxoSmithKline plc
- Bayer AG
- AstraZeneca
- Sanofi S.A.
- Zydus Cadila
- Others
Leading manufacturers operating in the global knee pain management market include Johnson & Johnson Services, Inc., F. Hoffman-La Roche AG, Amgen, Inc., Merck & Co., Inc., and Pfizer, Inc., Ferring B.V., GlaxoSmithKline plc, Bayer AG, AstraZeneca, Sanofi S.A., Zydus Cadila, and Others.
Our Clients
Related Reports
Some other reports from this category!
